Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Respiratory Syncytial Virus Vaccines
Study data from G. Meyer et al provide new insights into respiratory syncytial virus vaccines
June 4th, 2008
New research, 'Human and bovine respiratory syncytial virus vaccine research and development,' is the subject of a report. "Human (HRSV) and bovine (BRSV) respiratory syncytial viruses (RSV) are two closely related viruses, which are the most important causative agents of respiratory tract infections of young children and calves, respectively. BRSV vaccines have been available for nearly 2 decades," researchers in France report. "They probably have reduced the prevalence of RSV infection but their efficacy needs improvement. In contrast, despite decades of research, there is no currently licensed vaccine for the prevention of HRSV disease. Development of a HRSV vaccine...
Source: Vaccine Weekly (2008-06-04)
|
